Excel Diagnostics and Nuclear Oncology Center   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Houston TX United States (2003)

Organization Overview

First Clinical Trial
2010
NCT01237457
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Excel Diagnostics and Nuclear Oncology Center | Excel Diagnostics and Nuclear Oncology Clinic

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Neuroendocrine (Phase 2)

Carotid Body Tumor (Phase 2)

Neoplasms (Phase 2)

Neuroendocrine Tumors (Phase 2)

Paraganglioma (Phase 2)

Pheochromocytoma (Phase 2)

Prostatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 7